|
Ms. McDermott brings 10 years of operational experience in leading teams, managing key client relationships and overseeing programs throughout the drug development life cycle. Joining ICON in September 2003 when ICON acquired GloboMax LLC, she has held positions with increasing responsibility including Director, Project Management and Senior Director, Project Management, responsible for the division’s global Project Operations group.
Prior to joining ICON, Ms. McDermott managed the Project Management organization. Additionally, she oversaw multiple drug development programs/projects encompassing multiple scientific disciplines such as preclinical, manufacturing, clinical development, pharmacokinetics/pharmacometrics, and regulatory affairs. This work spanned broad therapeutic areas, including oncology, cardiovascular, gastrointestinal, CNS, immunology, and ophthalmology.
Gracelyn holds an MBA from Johns Hopkins University and is a certified Project Management Professional (PMP) with advanced training in the application of project management knowledge, skills and techniques. | 